With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:
Image source: Getty Images
CSL Ltd (ASX: CSL)
According to a note out of Citi, its analysts have retained their buy rating and $265.00 price target on this biotechnology company's shares. This follows news that US President Donald Trump is planning to put 100% tariffs on imported pharmaceutical products. While there are some uncertainties, Citi believes that CSL is well-placed to navigate these tariffs. It highlights that it collects the plasma for its immunoglobulins from US donors, which qualifies these products as US-origin. In addition, the company has significant operations in the US and the flexibility to revise its existing manufacturing plans to avoid being hit with the tariffs. The CSL share price is trading at $199.98 on Monday afternoon.
Premier Investments Ltd (ASX: PMV)
A note out of Bell Potter reveals that its analysts have retained their buy rating and $26.50 price target on this retail conglomerate's shares. This follows the release of the Peter Alexander and Smiggle owner's FY 2025 results last week. The broker was relatively pleased with the results and the marginal recovery in Smiggle's performance early in FY 2026. And while it has trimmed its earnings forecasts slightly, this has no impact on its valuation after time creep offset the changes. Overall, Bell Potter believes that Premier Investments is trading at a discount to peers, especially considering the Premier Retail division with two global roll-out worthy brands offering ~7% EBIT growth in FY 2026e and a P/E ratio of just ~12x excluding equity investments, land bank/cash, while also retaining a strong balance sheet which is supportive of M&A. The Premier Investments share price is fetching $19.23 at the time of writing.
Tabcorp Holdings Ltd (ASX: TAH)
Analysts at UBS have put a buy rating and $1.12 price target on this gambling company's shares. According to the note, the broker is feeling positive about Tabcorp following a review of its decent FY 2025 results and its evolved strategy. The latter is a broader strategy to leverage its unique offerings across Retail, Digital, and Media. This includes the creation of a structurally profitable retail business that will in time increase patronage to pubs and clubs with a true omnichannel offering. And it appears to be working based on UBS' data. As a result, it feels that Tabcorp could outperform consensus expectations in the near term. The Tabcorp share price is trading at $1.01 on Monday.
